Remission re-induction chemotherapy with clofarabine, topotecan, thiotepa, and vinorelbine for patients with relapsed or refractory leukemia

Pediatric Blood and Cancer

Volumn 54, Issue 5, 2010, Pages 687-693

  Steinherz, Peter G ^a   Shukla, Neerav ^a   Kobos, Rachel ^a   Steinherz, Laurel ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Acute leukemia; ALL; AML; Chemotherapy; Refractory; Relapsed

Indexed keywords

ANTIBIOTIC AGENT; ASPARAGINASE; CLOFARABINE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; GUANINE ARABINOSIDE; IDARUBICIN; METHOTREXATE; MITOXANTRONE; NAVELBINE; NELARABINE; PREDNISONE; THIOTEPA; TIOGUANINE; TOPOTECAN; VINCRISTINE; ADENINE NUCLEOTIDE; ANTINEOPLASTIC AGENT; ARABINONUCLEOSIDE; DRUG DERIVATIVE; VINBLASTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AMYLASE BLOOD LEVEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTEREMIA; BLOODSTREAM INFECTION; BONE MARROW HYPOPLASIA; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER REGRESSION; CELLULITIS; CHILD; CLINICAL ARTICLE; COLITIS; CONTINUOUS INFUSION; DEATH; DIARRHEA; DISEASE COURSE; DRUG DOSE ESCALATION; DRUG FEVER; DRUG MEGADOSE; ENTEROCOLITIS; FEBRILE NEUTROPENIA; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART ARREST; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPOTENSION; INFANT; INFECTION; LEUKEMIA RELAPSE; LIVER TOXICITY; LUNG INFECTION; MALE; MAXIMUM TOLERATED DOSE; MENINGITIS; NEUTROPENIA; PANCYTOPENIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RETREATMENT; SCHOOL CHILD; SEIZURE; SEPSIS; SIDE EFFECT; SINGLE DRUG DOSE; THROMBOCYTOPENIA; TREATMENT RESPONSE; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; VEIN OCCLUSION; VOMITING; DRUG ADMINISTRATION; DRUG TOXICITY; PATHOLOGY; RECURRENT DISEASE; REMISSION; SALVAGE THERAPY;

ADENINE NUCLEOTIDES; ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARABINONUCLEOSIDES; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; DRUG TOXICITY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; LEUKEMIA, MYELOID, ACUTE; MALE; MAXIMUM TOLERATED DOSE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECURRENCE; REMISSION INDUCTION; SALVAGE THERAPY; THIOTEPA; TOPOTECAN; VINBLASTINE;

EID: 77950483564     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22321     Document Type: Article

References (29)

1. Gaynon PS. Childhood acute lymphoblastic leukaemia and relapse. Br J Haematol 2005;131:579-587. (Pubitemid 43903802)
2. Weitman S, Ochoa S, Sullivan J, et al. Pediatric Phase I cancer chemotherapy trials: A Pediatric Oncology Group Study. J Pediatr Hematol Oncol 1997;19:187-191. (Pubitemid 27276282)
3. Kolb A, Steinherz P. A new multidrug re-induction protocol with topotecan, vinorelbine, thiotepa, dexamethasone, and gemcitabine (TVTG) for relapsed or refractory acute leukemia. Leukemia 2003;17:1967-1972.
4. Xie KC, PlunkettW. Deoxynucleotide pool depletion and sustained inhibition of ribonucleotide reductase and DNA synthesis after treatment of human lymphoblastoid cells with 2-chloro-9-(2-deoxy-2-fluoro-beta-D- arabinofuranosyl) adenine. Cancer Res 1996;56:3030-3037.
5. Genini D, Adachi S, Chao Q, et al. Deoxyadenosine analogs induce programmed cell death in chronic lymphocytic leukemia cells by damaging the DNA and by directly affecting the mitochondria. 2000;96:2537-3543.
6. Jeha S, Gandhi V, Chan KW, et al. Clorafabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia. Blood 2004;103:784-789. (Pubitemid 38129533)
7. Jeha S, Gaynon PS, Razzouk BL, et al. Phase II study by clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia. J Clin Oncol 2006;24:1917-1923. (Pubitemid 46638991)
8. Jeha S, Razzouk SB, Rytting M, et al. The phase II study of clofarabine for pediatric patients with refractory or relapsed acute myeloid leukemia. J Clin Oncol 2009;27:4392-4397. (Pubitemid 46638991)
9. Steinherz PG, Seibel N, Ames MM, et al. Phase I study of gemcitabine (difluorodeoxycytidine) in children with relapsed or refractory leukemia: A report from the Children's Cancer Group Leukemia & Lymphoma. 2002;43:1945-1950.
10. Horstmann MA, Hassenpflug WA, zur Stadt U, et al. Amsacrine combined with etoposide and high-dose methylprednisolone as salvage therapy in acute lymphoblastic leukemia in children. Haematologica 2005;90:1701-1703.
11. Dahl GV, Lacayo NJ, Brophy N, et al. Mitoxantrone, etoposide, and cyclosporine therapy in pediatric patients with recurrent or refractory acute myeloid leukemia. J Clin Oncol 2000;18:1867-1875. (Pubitemid 30261924)
12. Steinherz P, Meyers P, Wollner N, et al. Reinduction therapy for advanced or refractory acute lymphoblastic leukemia of childhood. Cancer 1989;63:1472-1476. (Pubitemid 19093267)
13. Wells RJ, Odom LF, Gold SH, et al. Cytosine arabinoside and mitoxantrone treatment of relapsed or refractory childhood leukemia: Initial response and relationship to multidrug resistance gene 1. Med Pediatr Oncol 1994;22:244-249.
14. Leblanc T, Demeocq F, Leverger G, et al. Treatment of relapsed or refractory acute leukemia in childhood with bisantrene combined with high dose aracytine. Med Pediatr Oncol 1994;22:119-124. (Pubitemid 24018601)
15. Ochs J, Rodman J, Abromowitch M, et al. A phase II study of combined methotrexate and teniposide infusion prior to reinduction therapy in relapsed childhood acute lymphoblastic leukemia: A Pediatric Oncology Group study. J Clin Oncol 1991;9:139-144.
16. Boulad F, Steinherz P, Reyes B, et al. Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission - A single institution study. J Clin Oncol 1999;17:197-207. (Pubitemid 29022394)
17. Steinherz PG, Meyers PA, Steinherz LJ, et al. Clofarabine induced durable complete remission in heavily pretreated adolescents with relapsed and refractory leukemia. J Pedriatr Hematol Oncol 2007;29:656-658.
18. Or R, Mehta J, Nagler A. Neutropenic enterocolitis associated with autologous bone marrow transplantation. Bone Marrow Transplant 1992;9:383-385.
19. Shamberger RC, Weinstein HJ, Delorey MJ. The medical and surgical management of typhlitis in children with acute nonlymphocytic (myelogenous) leukemia. Cancer 1986;57:603-609.
20. Sloas MM, Flynn PM, Kaste SC. Typhlitis in children with cancer: A 30-year experience. Clin Infect Dis 1993;17:484-490.
21. Faderl S, Verstovesk S, Cortes J, et al. Clofarabine and cytarabine combination as induction therapy for acute myeloid leukemia (AML) in patients 50 years of age or older. Blood 2006;108:45-51. (Pubitemid 43990611)
22. Faderl S, Borthakur G, Ravandi F, et al. Results of a randomized phase 2 study of clofarabine plus cytarabine (CA) Vs clofarabine plus idarubicin (CI) Vs clofarabine, idarubicin, plus cytarabine (CIA) as salvage therapy in acute myeloid leukemia (AML). Blood 2008;112:354 (Abstract #964).
23. Faderl S, Ravandi F, Huang X, et al. A randomized study of clofarabine versus clofarabine and low-dose cytarabine as fron-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplasia syndrome. Blood 2008;112:1638-1645.
24. Thomas X, Lobe I, Raffoux E, et al. Intensive consolidation with clofarabine and intermediate-dose cytarabine (CLARA) in patients with high-riskAMLin first CR: The ALFA-0702 pilot study. Blood 2008;112:675 (Abstract #1934).
25. Bayard P, D'Agostino R, Jr., Levitan D, et al. High dose cytarabine and clofarabine (HiDAC→CLOF) in relapsed or refractory acute myeloid leukemia, a phase 2 trial. Blood 2008;112:676 (Abstract #1936).
26. Becker PS, Estey E, Petersdorf S, et al. Phase I trial of clofarabine and high dose cytarabine with G-CSF priming (G-CLAC) for relapsed or refractory acute myeloid leukemia. Blood 2008;112:1018 (Abstract #2964).
27. Mineishi S, Magenau J, Pawarode A, et al. Myeloablative conditioning with clofarabine and busulfan x 4 (CloBu4) is well tolerated, facilitates secure engraftment, and exhibits significant anti-tumor activity against non-remission hematologic malignancies including AML. 2008;112:749. (Abstract #2150).
28. Hijiya N, Gaynon P, Fernandez M, et al. Durable remissions observed in a phase I/II study of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute leukemia. Blood 2008;112:1006 (Abstract #2925).
29. Hijiya N, Gaynon P, Barry E, et al. A multi-center phase I study of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute leukemia. Leukemia 2009;23:2259-2264.